Medication info
Telmita Plus 40/12.5 mg Tablets

Telmita Plus 40/12.5 mg Tablets

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Ilsung IS Co., Ltd.
Appearance
Oval-shaped tablets consisting of two layers in white/pink, with the white layer possibly having pink specks.
Packaging
30 tablets (10 tablets/ PTP×3)
Approval status
Active

MFDS item code 201000950 · Notified 2010.01.28 · Insurance code 655402880

Summary

Main use
Treatment of essential hypertension not controlled with telmisartan alone
Who takes it
Adults · Children
Adult dose
Adults For patients whose blood pressure is not adequately controlled with telmisartan alone, take once daily with a drink, with or without food. Before switching to this drug, which contains fixed doses of each component, it is recommended that the dose of each component be individually adjusted separately. When clinically appropriate, a direct switch from monotherapy to this drug may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg given concomitantly as separate products or as a combination product. Sodium or volume depletion should be corrected before starting this drug. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment. This drug should not be administered to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This drug should be administered with caution to patients with mild to moderate hepatic impairment. The daily dose of this drug should not exceed 40/12.5mg. This drug should not be administered to patients with severe hepatic impairment (see Precautions for Use 2.). Thiazide diuretics should be administered with caution to patients with impaired liver function. Elderly patients No dose adjustment is necessary.
Child dose
The safety and efficacy of this drug have not been established in children under 18 years of age.

Ingredients

Manufacturer
Ilsung IS Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with telmisartan alone

  • Essential hypertension
View approved original text

This medication is used in patients with essential hypertension who have difficulty controlling blood pressure with telmisartan alone. It helps to effectively lower blood pressure, reducing the risk of cardiovascular diseases and improving the health of patients.

How to take

Adult dose

Adults For patients whose blood pressure is not adequately controlled with telmisartan alone, take once daily with a drink, with or without food. Before switching to this drug, which contains fixed doses of each component, it is recommended that the dose of each component be individually adjusted separately. When clinically appropriate, a direct switch from monotherapy to this drug may also be considered. - The telmisartan/hydrochlorothiazide combination 40/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 40mg. - The telmisartan/hydrochlorothiazide combination 80/12.5mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg. - The telmisartan/hydrochlorothiazide combination 80/25mg may be administered to patients whose blood pressure is not adequately controlled with telmisartan 80mg and hydrochlorothiazide 12.5mg given concomitantly as separate products or as a combination product. Sodium or volume depletion should be corrected before starting this drug. Patients with renal impairment No dose adjustment is necessary in patients with mild to moderate renal impairment. This drug should not be administered to patients with severe renal impairment (creatinine clearance<30mL/min). Periodic monitoring of renal function is recommended. Patients with hepatic impairment This drug should be administered with caution to patients with mild to moderate hepatic impairment. The daily dose of this drug should not exceed 40/12.5mg. This drug should not be administered to patients with severe hepatic impairment (see Precautions for Use 2.). Thiazide diuretics should be administered with caution to patients with impaired liver function. Elderly patients No dose adjustment is necessary.

Child dose

The safety and efficacy of this drug have not been established in children under 18 years of age.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, especially in the second and third trimesters; therefore, it should be stopped immediately upon confirmation of pregnancy. Patients with allergies to the ingredients of this medication or with certain liver or kidney diseases should not use it. Elderly patients or those with high potassium levels in the blood, or those with impaired liver function should use this medication cautiously. It may increase the risk of skin cancer; thus, sun exposure should be avoided, and skin condition should be monitored regularly. Since this medication lowers blood pressure, dizziness or symptoms of low blood pressure may occur, so caution is needed when driving or operating machinery. During the use of this medication, regular checks of electrolyte levels in the blood and kidney function should be conducted to ensure no abnormalities. Additionally, since interactions may occur when taking this medication with other antihypertensives, diuretics, or potassium supplements, consultation with a physician is advised. In cases of overdose, symptoms such as low blood pressure, cardiac arrhythmias, and electrolyte imbalances may occur. In such cases, immediate medical attention should be sought. This medication is not recommended for children under 18 years of age as its safety and efficacy have not been established.

Side effects

  • Bronchitis
  • pharyngitis
  • sinusitis
  • hypokalemia
  • hyperuricemia
  • hyponatremia
  • anxiety
  • depression
  • insomnia
  • sleep disorders
Show 151 more
  • dizziness
  • syncope
  • paresthesia
  • visual impairment
  • blurred vision
  • vertigo
  • tachycardia
  • arrhythmia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • respiratory distress
  • pneumonia
  • pulmonary edema
  • diarrhea
  • dry mouth
  • bloating
  • abdominal pain
  • constipation
  • dyspepsia
  • vomiting
  • gastritis
  • liver function abnormalities
  • liver impairment
  • angioedema
  • erythema
  • pruritus
  • rash
  • hyperhidrosis
  • urticaria
  • back pain
  • muscle spasms
  • myalgia
  • arthralgia
  • limb pain
  • systemic lupus erythematosus
  • erectile dysfunction
  • chest pain
  • influenza-like illness
  • pain
  • increased blood uric acid
  • increased blood creatinine
  • increased blood creatine phosphokinase
  • elevated liver enzymes
  • upper respiratory tract infection
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • eosinophilia
  • thrombocytopenia
  • anaphylactic reaction
  • hypersensitivity
  • hyperkalemia
  • hypoglycemia
  • drowsiness
  • bradycardia
  • cough
  • interstitial lung disease
  • dry mouth
  • abdominal discomfort
  • taste disturbance
  • eczema
  • drug rash
  • toxic skin rash
  • abdominal pain
  • renal dysfunction
  • weakness
  • influenza-like illness
  • increased blood creatinine
  • increased blood uric acid
  • increased blood creatine phosphokinase
  • decreased hemoglobin
  • sialadenitis
  • non-melanoma skin cancer
  • thrombocytopenic purpura
  • hemolytic anemia
  • bone marrow failure
  • leukopenia
  • agranulocytosis
  • hypersensitivity
  • anaphylactic reaction
  • hypokalemia
  • hyperlipidemia
  • hyponatremia
  • decreased appetite
  • hypomagnesemia
  • hyperglycemia
  • hypercalcemia
  • hypochloremic alkalosis
  • depression
  • sleep disorders
  • dizziness
  • paresthesia
  • headache
  • visual impairment
  • yellow vision
  • acute myopia
  • angle-closure glaucoma
  • choroidal exudate
  • arrhythmia
  • orthostatic hypotension
  • necrotizing vasculitis
  • respiratory distress
  • pneumonia
  • pulmonary edema
  • acute respiratory distress syndrome
  • nausea
  • pancreatitis
  • jaundice
  • cholestasis
  • phototoxic reaction
  • toxic epidermal necrolysis
  • lupus-like syndrome
  • systemic lupus erythematosus
  • muscle spasms
  • acute renal failure
  • diabetes
  • renal dysfunction
  • erectile dysfunction
  • weakness
  • fever
  • dizziness
  • diarrhea
  • cough
  • itching
  • myalgia
  • headache
  • floating sensation
  • headache
  • lip and hand tremors
  • sensory hypersensitivity
  • gum disease
  • dry lips
  • vision impairment
  • hypoglycemia
  • intestinal edema
  • nausea
  • abdominal pain
  • gastrointestinal bleeding
  • esophagitis
  • dyspepsia
  • headache
  • tremors
  • upper respiratory tract infection
  • facial flushing
  • malaise
  • fatigue
  • weight loss
  • increased creatine phosphokinase
  • anxiety

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to protect it from air and moisture. It is advisable to keep the storage temperature between 1 and 30 degrees Celsius. This will help maintain the effectiveness of the medication and prevent degradation.

Appearance and packaging

Appearance

Oval-shaped tablets consisting of two layers in white/pink, with the white layer possibly having pink specks.

Package unit

30 tablets (10 tablets/ PTP×3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.